huahaipharm(SH:600521) Zhong Guo Zheng Quan Bao - Zhong Zheng Wang·2026-01-06 07:55Group 1 - The core viewpoint of the news is that Zhejiang Huahai Pharmaceutical Co., Ltd. has undergone a site inspection by its sponsor, Zheshang Securities, which found that the company is operating well in terms of corporate governance, internal control, and compliance with regulations [1][12] Group 2 - The site inspection was conducted on December 30, 2025, and involved reviewing the company's governance documents, internal control systems, and financial practices [3][4] - The inspection confirmed that the company has a complete governance structure and that its internal control systems are effectively implemented [2][4] - The company has maintained independence from its controlling shareholders and has not engaged in any improper transactions with related parties [4][5] Group 3 - The use of raised funds was found to be compliant, with all funds stored in designated accounts and no evidence of misuse or unauthorized changes in fund allocation [5][6] - There were no violations related to external guarantees, related transactions, or significant external investments during the inspection period [5][6] Group 4 - The company's operational status remains stable, with no significant adverse changes in its business model or structure [6][12] - The company is advised to continue enhancing its corporate governance and risk management practices to ensure accurate and complete information disclosure [8]